Administration of Moxifloxacin 0.5%/Dexamethasone 0.1% Ophthalmic Solution
Instill one drop of the fixed-combination moxifloxacin 0.5%/dexamethasone 0.1% ophthalmic solution into the affected eye(s) four times daily for 7-15 days, depending on the clinical indication.
Dosing Regimen by Clinical Context
For Bacterial Blepharitis or Conjunctivitis
- Standard dosing: 1 drop four times daily for 7 days 1
- This regimen achieved 81.6% clinical resolution in bacterial blepharitis with excellent tolerability 1
For Post-Cataract Surgery Prophylaxis
- Standard dosing: 1 drop four times daily starting 2 days before surgery and continuing for 15 days postoperatively 2, 3
- Begin 2 days preoperatively to establish therapeutic levels
- Continue through postoperative day 15 to prevent infection and control inflammation
- This approach achieved 91.7% of patients with minimal anterior chamber reaction (grade 0) by day 15 2
For Post-LASIK Prophylaxis
- Standard dosing: 1 drop four times daily starting 2 days before surgery and continuing for 15 days postoperatively 4
- Same preoperative initiation as cataract surgery
Administration Technique
Proper instillation steps:
- Wash hands thoroughly before administration
- Tilt head back and pull lower eyelid down to create a pocket
- Instill 1 drop into the conjunctival sac
- Avoid touching the dropper tip to any surface, including the eye
- Close eye gently for 1-2 minutes after instillation
- Apply gentle pressure to the lacrimal sac (nasolacrimal occlusion) to minimize systemic absorption
Storage Requirements
- Store at 2°C to 25°C (36°F to 77°F) 5, 6
- Keep bottle tightly closed when not in use
- Discard 28 days after opening (standard practice for multi-dose ophthalmic solutions)
Critical Monitoring Parameters
For patients on prolonged therapy (>7 days):
- Monitor intraocular pressure (IOP) periodically due to dexamethasone component 7
- Perform pupillary dilation to evaluate for cataract formation with extended use 7
- Taper corticosteroid component once inflammation is controlled 7
Common pitfall: The dexamethasone component can elevate IOP and promote cataract formation with prolonged use. Use the minimum effective duration and consider switching to corticosteroids with poor ocular penetration (fluorometholone or loteprednol) if extended therapy beyond 15 days is needed 7.
Therapeutic Equivalence
The fixed-combination formulation is therapeutically equivalent to administering moxifloxacin 0.5% and dexamethasone 0.1% as separate drops 1, 3, 4. The fixed combination offers superior convenience with identical efficacy, improving patient adherence by reducing the number of bottles and instillations required.
Contraindications and Precautions
Avoid in:
- Herpes simplex virus (HSV) keratitis or conjunctivitis—topical corticosteroids potentiate HSV epithelial infections 7
- Fungal or viral ocular infections where corticosteroids are contraindicated
- Patients with known hypersensitivity to fluoroquinolones or corticosteroids
Use with caution in:
- Patients with history of steroid-responsive IOP elevation
- Prolonged use beyond 2 weeks (risk of glaucoma and cataract)